{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:07:50Z","timestamp":1792825670518,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Denis and Diane Lyman Foundation, Faulk Foundation"},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05579-w","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T02:51:51Z","timestamp":1765853511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["miRNA Biomarkers Diagnose Amyotrophic Lateral Sclerosis in Circulating Blood"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7816-3251","authenticated-orcid":false,"given":"Rachael Anne","family":"Dunlop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6401-2981","authenticated-orcid":false,"given":"Paul Alan","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah W.","family":"Stommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5183-2702","authenticated-orcid":false,"given":"Sandra Anne","family":"Banack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"issue":"3-4","key":"5579_CR1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/21678421.2024.2447919","volume":"26","author":"P Mehta","year":"2025","unstructured":"Mehta P, Raymond J, Nair T et al (2025) Amyotrophic lateral sclerosis estimated prevalence cases from 2022 to 2030, data from the national ALS Registry. Amyotroph Lateral Scler Frontotemporal Degener 26(3\u20134):290\u2013295. https:\/\/doi.org\/10.1080\/21678421.2024.2447919","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"5579_CR2","unstructured":"Mitsumoto H, Chad DA, Pioro EP (1998) Amyotrophic Lateral Sclerosis. Oxford University Press."},{"issue":"6","key":"5579_CR3","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1007\/s00415-019-09276-2","volume":"266","author":"T Shimizu","year":"2019","unstructured":"Shimizu T, Nakayama Y, Matsuda C et al (2019) Prognostic significance of body weight variation after diagnosis in ALS: a single-centre prospective cohort study. J Neurol 266(6):1412\u20131420. https:\/\/doi.org\/10.1007\/s00415-019-09276-2","journal-title":"J Neurol"},{"issue":"1","key":"5579_CR4","doi-asserted-by":"publisher","first-page":"12262","DOI":"10.1038\/s41598-019-48831-9","volume":"9","author":"Y Nakayama","year":"2019","unstructured":"Nakayama Y, Shimizu T, Matsuda C et al (2019) Body weight variation predicts disease progression after invasive ventilation in amyotrophic lateral sclerosis. Sci Rep 9(1):12262. https:\/\/doi.org\/10.1038\/s41598-019-48831-9","journal-title":"Sci Rep"},{"key":"5579_CR5","doi-asserted-by":"crossref","unstructured":"Verma A (2021) Clinical manifestation and management of amyotrophic lateral sclerosis. In: Araki T, ed. Amyotrophic Lateral Sclerosis. Exon Publications. Accessed June 4, 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK573427\/","DOI":"10.36255\/exonpublications.amyotrophiclateralsclerosis.management.2021"},{"issue":"10","key":"5579_CR6","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori P, Van Damme P (2020) Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol 27(10):1918\u20131929. https:\/\/doi.org\/10.1111\/ene.14393","journal-title":"Eur J Neurol"},{"issue":"5","key":"5579_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1(5):293\u2013299. https:\/\/doi.org\/10.1080\/146608200300079536","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"5579_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117054","volume":"417","author":"D Richards","year":"2020","unstructured":"Richards D, Morren JA, Pioro EP (2020) Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis. J Neurol Sci 417:117054. https:\/\/doi.org\/10.1016\/j.jns.2020.117054","journal-title":"J Neurol Sci"},{"issue":"1-2","key":"5579_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/21678421.2023.2260808","volume":"25","author":"NA Goyal","year":"2024","unstructured":"Goyal NA, Bonar K, Savic N et al (2024) Misdiagnosis of amyotrophic lateral sclerosis in clinical practice in Europe and the USA: a patient chart review and physician survey. Amyotroph Lateral Scler Frontotemporal Degener 25(1\u20132):16\u201325. https:\/\/doi.org\/10.1080\/21678421.2023.2260808","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"6","key":"5579_CR10","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/mus.28390","volume":"71","author":"S Chen","year":"2025","unstructured":"Chen S, Carter D, Prier J et al (2025) Racial disparities in ALS progression: time to clinical events observed in a single center. Muscle Nerve 71(6):1086\u20131090. https:\/\/doi.org\/10.1002\/mus.28390","journal-title":"Muscle Nerve"},{"key":"5579_CR11","unstructured":"Brooks BR (1999) Earlier is better: the benefits of early diagnosis. Neurology 53(8 Suppl 5):S53\u201354. (discussion S55\u201357)"},{"key":"5579_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6534150","volume":"2018","author":"OA Khairoalsindi","year":"2018","unstructured":"Khairoalsindi OA, Abuzinadah AR (2018) Maximizing the survival of Amyotrophic Lateral Sclerosis patients: current perspectives. Neurol Res Int 2018:6534150. https:\/\/doi.org\/10.1155\/2018\/6534150","journal-title":"Neurol Res Int"},{"issue":"5","key":"5579_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae268","volume":"6","author":"SA Banack","year":"2024","unstructured":"Banack SA, Dunlop RA, Mehta P et al (2024) A microRNA diagnostic biomarker for amyotrophic lateral sclerosis. Brain Commun 6(5):fcae268. https:\/\/doi.org\/10.1093\/braincomms\/fcae268","journal-title":"Brain Commun"},{"key":"5579_CR14","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.200116","author":"SA Banack","year":"2020","unstructured":"Banack SA, Dunlop RA, Cox PA (2020) An miRNA fingerprint using neural-enriched extracellular vesicles from blood plasma: towards a biomarker for amyotrophic lateral sclerosis\/motor neuron disease. Open Biol. https:\/\/doi.org\/10.1098\/rsob.200116","journal-title":"Open Biol"},{"key":"5579_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120396","author":"SA Banack","year":"2022","unstructured":"Banack SA, Dunlop RA, Stommel EW, Mehta P, Cox PA (2022) miRNA extracted from extracellular vesicles is a robust biomarker of amyotrophic lateral sclerosis. J Neurol Sci. https:\/\/doi.org\/10.1016\/j.jns.2022.120396","journal-title":"J Neurol Sci"},{"issue":"1","key":"5579_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/biomethods\/bpab015","volume":"6","author":"RA Dunlop","year":"2021","unstructured":"Dunlop RA, Banack SA, Cox PA (2021) A comparison of the efficiency of RNA extraction from extracellular vesicles using the Qiagen RNeasy MinElute versus Enzymax LLC RNA Tini Spin columns and qPCR of miRNA. Biol Methods Protoc 6(1):1\u20139. https:\/\/doi.org\/10.1093\/biomethods\/bpab015","journal-title":"Biol Methods Protoc"},{"issue":"1","key":"5579_CR17","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ymeth.2012.09.015","volume":"59","author":"T Blondal","year":"2013","unstructured":"Blondal T, Jensby Nielsen S, Baker A et al (2013) Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods 59(1):S1\u2013S6. https:\/\/doi.org\/10.1016\/j.ymeth.2012.09.015","journal-title":"Methods"},{"issue":"7","key":"5579_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/genes13071288","volume":"13","author":"MD Smith","year":"2022","unstructured":"Smith MD, Leemaqz SY, Jankovic-Karasoulos T et al (2022) Haemolysis detection in MicroRNA-Seq from clinical plasma samples. Genes 13(7):1288. https:\/\/doi.org\/10.3390\/genes13071288","journal-title":"Genes"},{"issue":"1","key":"5579_CR19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12859-021-04306-1","volume":"22","author":"A Untergasser","year":"2021","unstructured":"Untergasser A, Ruijter JM, Benes V, van den Hoff MJB (2021) Web-based LinRegPCR: application for the visualization and analysis of (RT)-qPCR amplification and melting data. BMC Bioinformatics 22(1):398. https:\/\/doi.org\/10.1186\/s12859-021-04306-1","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"5579_CR20","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1093\/bioinformatics\/btq037","volume":"26","author":"B Hanczar","year":"2010","unstructured":"Hanczar B, Hua J, Sima C, Weinstein J, Bittner M, Dougherty ER (2010) Small-sample precision of ROC-related estimates. Bioinformatics 26(6):822\u2013830. https:\/\/doi.org\/10.1093\/bioinformatics\/btq037","journal-title":"Bioinformatics"},{"key":"5579_CR21","unstructured":"Core Team R (2021) R Core Team, R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Accessed 14 May 2025. https:\/\/www.r-project.org\/"},{"key":"5579_CR22","unstructured":"Barrett T, Dowle M, Srinivasan A et al (2025) data.table: extension of \u201cdata.frame\u201d 2025 R Package version 1.17.0. Accessed 14 May, 2025. https:\/\/r-datatable.com"},{"key":"5579_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"JH Friedman","year":"2010","unstructured":"Friedman JH, Hastie T, Tibshirani R (2010) Regularization paths for generalized linear models via coordinate descent. J Stat Softw 33:1\u201322. https:\/\/doi.org\/10.18637\/jss.v033.i01","journal-title":"J Stat Softw"},{"key":"5579_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v106.i01","volume":"106","author":"JK Tay","year":"2023","unstructured":"Tay JK, Narasimhan B, Hastie T (2023) Elastic net regularization paths for all generalized linear models. J Stat Softw 106:1\u201331. https:\/\/doi.org\/10.18637\/jss.v106.i01","journal-title":"J Stat Softw"},{"key":"5579_CR25","unstructured":"Xie Y (2021) knitr: a general-purpose package for dynamic report generation in R. Accessed May 14, 2025. https:\/\/yihui.org\/knitr\/"},{"key":"5579_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","volume":"28","author":"M Kuhn","year":"2008","unstructured":"Kuhn M (2008) Building predictive models in R using the caret package. J Stat Softw 28:1\u201326. https:\/\/doi.org\/10.18637\/jss.v028.i05","journal-title":"J Stat Softw"},{"issue":"3-4","key":"5579_CR27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/21678421.2018.1550517","volume":"20","author":"F Palese","year":"2019","unstructured":"Palese F, Sartori A, Logroscino G, Pisa FE (2019) Predictors of diagnostic delay in amyotrophic lateral sclerosis: a cohort study based on administrative and electronic medical records data. Amyotroph Lateral Scler Frontotemporal Degener 20(3\u20134):176\u2013185. https:\/\/doi.org\/10.1080\/21678421.2018.1550517","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"4","key":"5579_CR28","doi-asserted-by":"publisher","first-page":"fcab242","DOI":"10.1093\/braincomms\/fcab242","volume":"3","author":"C Wong","year":"2021","unstructured":"Wong C, Stavrou M, Elliott E et al (2021) Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective. Brain Commun 3(4):fcab242. https:\/\/doi.org\/10.1093\/braincomms\/fcab242","journal-title":"Brain Commun"},{"key":"5579_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105323","volume":"108","author":"M Benatar","year":"2024","unstructured":"Benatar M, Macklin EA, Malaspina A et al (2024) Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis. EBioMedicine 108:105323. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105323","journal-title":"EBioMedicine"},{"issue":"3","key":"5579_CR30","doi-asserted-by":"publisher","first-page":"fcad163","DOI":"10.1093\/braincomms\/fcad163","volume":"5","author":"JC Davies","year":"2023","unstructured":"Davies JC, Dharmadasa T, Thompson AG et al (2023) Limited value of serum neurofilament light chain in diagnosing amyotrophic lateral sclerosis. Brain Commun 5(3):fcad163. https:\/\/doi.org\/10.1093\/braincomms\/fcad163","journal-title":"Brain Commun"},{"issue":"12","key":"5579_CR31","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jamaneurol.2023.3997","volume":"80","author":"A Abdelhak","year":"2023","unstructured":"Abdelhak A, Benkert P, Schaedelin S et al (2023) Neurofilament light chain elevation and disability progression in multiple sclerosis. JAMA Neurol 80(12):1317\u20131325. https:\/\/doi.org\/10.1001\/jamaneurol.2023.3997","journal-title":"JAMA Neurol"},{"issue":"1","key":"5579_CR32","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1212\/WNL.0000000000004761","volume":"90","author":"E Feneberg","year":"2018","unstructured":"Feneberg E, Oeckl P, Steinacker P et al (2018) Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis. Neurology 90(1):e22\u2013e30. https:\/\/doi.org\/10.1212\/WNL.0000000000004761","journal-title":"Neurology"},{"issue":"8","key":"5579_CR33","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1002\/acn3.52126","volume":"11","author":"T Koch","year":"2024","unstructured":"Koch T, Fabian R, Weinhold L et al (2024) Cardiac troponin T as a serum biomarker of respiratory impairment in amyotrophic lateral sclerosis. Ann Clin Transl Neurol 11(8):2063\u20132072. https:\/\/doi.org\/10.1002\/acn3.52126","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"5579_CR34","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s13760-021-01743-w","volume":"122","author":"E Aksu-Menges","year":"2022","unstructured":"Aksu-Menges E, Balci-Hayta B, Bekircan-Kurt CE, Aydinoglu AT, Erdem-Ozdamar S, Tan E (2022) Two distinct skeletal muscle microRNA signatures revealing the complex mechanism of sporadic ALS. Acta Neurol Belg 122(6):1499\u20131509. https:\/\/doi.org\/10.1007\/s13760-021-01743-w","journal-title":"Acta Neurol Belg"},{"key":"5579_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.855096","author":"M Alvia","year":"2022","unstructured":"Alvia M, Aytan N, Spencer KR et al (2022) MicroRNA alterations in chronic traumatic encephalopathy and amyotrophic lateral sclerosis. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2022.855096","journal-title":"Front Neurosci"},{"issue":"3","key":"5579_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04217-1","volume":"79","author":"M Rizzuti","year":"2022","unstructured":"Rizzuti M, Melzi V, Gagliardi D et al (2022) Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes. Cell Mol Life Sci 79(3):189. https:\/\/doi.org\/10.1007\/s00018-022-04217-1","journal-title":"Cell Mol Life Sci"},{"key":"5579_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2024.1457704","volume":"18","author":"BP Dash","year":"2024","unstructured":"Dash BP, Freischmidt A, Helferich AM et al (2024) Upregulated miR-10b-5p as a potential miRNA signature in amyotrophic lateral sclerosis patients. Front Cell Neurosci 18:1457704. https:\/\/doi.org\/10.3389\/fncel.2024.1457704","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"5579_CR38","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1007\/s12035-022-02789-4","volume":"59","author":"Y Yu","year":"2022","unstructured":"Yu Y, Pang D, Li C et al (2022) The expression discrepancy and characteristics of long non-coding RNAs in peripheral blood leukocytes from amyotrophic lateral sclerosis patients. Mol Neurobiol 59(6):3678\u20133689. https:\/\/doi.org\/10.1007\/s12035-022-02789-4","journal-title":"Mol Neurobiol"},{"issue":"1","key":"5579_CR39","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1080\/07853890.2022.2138530","volume":"54","author":"G Joilin","year":"2022","unstructured":"Joilin G, Gray E, Thompson AG et al (2022) Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patients. Ann Med 54(1):3069\u20133078. https:\/\/doi.org\/10.1080\/07853890.2022.2138530","journal-title":"Ann Med"},{"key":"5579_CR40","doi-asserted-by":"publisher","unstructured":"Alkhazaali-Ali Z, Sahab-Negah S, Boroumand AR et al (2025) Evaluation of safety and efficacy of repeated mesenchymal stem cell transplantation in patients with amyotrophic lateral sclerosis (ALS) by investigating patient\u2019s specific microRNAs as novel biomarkers: a clinical trial study. Curr Stem Cell Res Ther. Published online January 29, 2025. https:\/\/doi.org\/10.2174\/011574888X330199250106081717","DOI":"10.2174\/011574888X330199250106081717"},{"issue":"12","key":"5579_CR41","doi-asserted-by":"publisher","first-page":"7557","DOI":"10.1007\/s00415-024-12699-1","volume":"271","author":"D Gagliardi","year":"2024","unstructured":"Gagliardi D, Rizzuti M, Masrori P et al (2024) Exploiting the role of CSF NfL, CHIT1, and miR-181b as potential diagnostic and prognostic biomarkers for ALS. J Neurol 271(12):7557\u20137571. https:\/\/doi.org\/10.1007\/s00415-024-12699-1","journal-title":"J Neurol"},{"issue":"1","key":"5579_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s12017-024-08773-6","volume":"26","author":"A Musar\u00f2","year":"2024","unstructured":"Musar\u00f2 A, Dobrowolny G, Cambieri C et al (2024) MiR206 and 423-3p are differently modulated in fast and slow-progressing amyotrophic lateral sclerosis patients. Neuromolecular Med 26(1):5. https:\/\/doi.org\/10.1007\/s12017-024-08773-6","journal-title":"Neuromolecular Med"},{"issue":"6","key":"5579_CR43","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1093\/hmg\/ddac250","volume":"32","author":"J Hur","year":"2023","unstructured":"Hur J, Paez-Colasante X, Figueroa-Romero C et al (2023) miRNA analysis reveals novel dysregulated pathways in amyotrophic lateral sclerosis. Hum Mol Genet 32(6):934\u2013947. https:\/\/doi.org\/10.1093\/hmg\/ddac250","journal-title":"Hum Mol Genet"},{"issue":"1","key":"5579_CR44","doi-asserted-by":"publisher","first-page":"14976","DOI":"10.1038\/s41598-025-99206-2","volume":"15","author":"D Francesca","year":"2025","unstructured":"Francesca D, Rosalinda DG, Luca D et al (2025) Cross-tissue MiRNA profiling of extracellular vesicles and PBMCs from amyotrophic lateral sclerosis patients. Sci Rep 15(1):14976. https:\/\/doi.org\/10.1038\/s41598-025-99206-2","journal-title":"Sci Rep"},{"key":"5579_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.106871","volume":"208","author":"EP Cuevas","year":"2025","unstructured":"Cuevas EP, Madruga E, Valenzuela-Mart\u00ednez I et al (2025) MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers. Neurobiol Dis 208:106871. https:\/\/doi.org\/10.1016\/j.nbd.2025.106871","journal-title":"Neurobiol Dis"},{"issue":"9","key":"5579_CR46","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/life14091125","volume":"14","author":"R Wang","year":"2024","unstructured":"Wang R, Chen L, Zhang Y, Sun B, Liang M (2024) Expression changes of miRNAs in Humans and animal models of amyotrophic lateral sclerosis and their potential application for clinical diagnosis. Life 14(9):1125. https:\/\/doi.org\/10.3390\/life14091125","journal-title":"Life"},{"issue":"3","key":"5579_CR47","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2144\/000114002","volume":"54","author":"N Redshaw","year":"2013","unstructured":"Redshaw N, Wilkes T, Whale A, Cowen S, Huggett J, Foy CA (2013) A comparison of miRNA isolation and RT-qPCR technologies and their effects on quantification accuracy and repeatability. Biotechniques 54(3):155\u2013164. https:\/\/doi.org\/10.2144\/000114002","journal-title":"Biotechniques"},{"issue":"4","key":"5579_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/biom13040706","volume":"13","author":"P Ruffo","year":"2023","unstructured":"Ruffo P, Catalano S, La Bella V, Conforti FL (2023) Deregulation of plasma microRNA expression in a TARDBP-ALS family. Biomolecules 13(4):706. https:\/\/doi.org\/10.3390\/biom13040706","journal-title":"Biomolecules"},{"issue":"1","key":"5579_CR49","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41598-022-05067-4","volume":"12","author":"N Daneshafrooz","year":"2022","unstructured":"Daneshafrooz N, Joghataei MT, Mehdizadeh M et al (2022) Identification of let-7f and miR-338 as plasma-based biomarkers for sporadic amyotrophic lateral sclerosis using meta-analysis and empirical validation. Sci Rep 12(1):1373. https:\/\/doi.org\/10.1038\/s41598-022-05067-4","journal-title":"Sci Rep"},{"issue":"1","key":"5579_CR50","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1038\/s41598-023-32717-y","volume":"13","author":"JA Kim","year":"2023","unstructured":"Kim JA, Park C, Sung JJ, Seo DJ, Choi SJ, Hong YH (2023) Small RNA sequencing of circulating small extracellular vesicles microRNAs in patients with amyotrophic lateral sclerosis. Sci Rep 13(1):5528. https:\/\/doi.org\/10.1038\/s41598-023-32717-y","journal-title":"Sci Rep"},{"key":"5579_CR51","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.brainresbull.2023.01.005","volume":"194","author":"H Liu","year":"2023","unstructured":"Liu H, Lan S, Shi XJ et al (2023) Systematic review and meta-analysis on microRNAs in amyotrophic lateral sclerosis. Brain Res Bull 194:82\u201389. https:\/\/doi.org\/10.1016\/j.brainresbull.2023.01.005","journal-title":"Brain Res Bull"},{"issue":"12","key":"5579_CR52","doi-asserted-by":"publisher","first-page":"7104","DOI":"10.1007\/s12035-023-03520-7","volume":"60","author":"BC Gomes","year":"2023","unstructured":"Gomes BC, Peixinho N, Pisco R et al (2023) Differential expression of miRNAs in amyotrophic lateral sclerosis patients. Mol Neurobiol 60(12):7104\u20137117. https:\/\/doi.org\/10.1007\/s12035-023-03520-7","journal-title":"Mol Neurobiol"},{"issue":"5","key":"5579_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054610","volume":"24","author":"E Giagnorio","year":"2023","unstructured":"Giagnorio E, Malacarne C, Cavalcante P et al (2023) MiR-146a in ALS: contribution to early peripheral nerve degeneration and relevance as disease biomarker. Int J Mol Sci 24(5):4610. https:\/\/doi.org\/10.3390\/ijms24054610","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5579_CR54","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.jspi.2007.09.015","volume":"139","author":"JD Blume","year":"2009","unstructured":"Blume JD (2009) Bounding sample size projections for the area under a ROC curve. J Stat Plan Inference 139(1):711\u2013721. https:\/\/doi.org\/10.1016\/j.jspi.2007.09.015","journal-title":"J Stat Plan Inference"},{"issue":"1","key":"5579_CR55","doi-asserted-by":"publisher","first-page":"33846","DOI":"10.1038\/s41598-025-04322-8","volume":"15","author":"A Rawat","year":"2025","unstructured":"Rawat A, Khurana S, Verma S et al (2025) Insights from meta-analysis and experimental validation identify exosomal miR-146a-5p as a potential biomarker for sporadic amyotrophic lateral sclerosis. Sci Rep 15(1):33846","journal-title":"Sci Rep"},{"issue":"4","key":"5579_CR56","first-page":"38","volume":"79","author":"DK Horton","year":"2016","unstructured":"Horton DK, Kaye W, Wagner L (2016) Integrating a biorepository into the national amyotrophic lateral sclerosis registry. J Environ Health 79(4):38\u201340","journal-title":"J Environ Health"},{"key":"5579_CR57","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1007\/s40615-024-02099-6","volume":"12","author":"J Raymond","year":"2025","unstructured":"Raymond J, Nair T, Gwathmey KG et al (2025) Racial disparities in the diagnosis and prognosis of ALS patients in the United States. J Racial Ethn Health Disparities 12:2915\u20132921. https:\/\/doi.org\/10.1007\/s40615-024-02099-6","journal-title":"J Racial Ethn Health Disparities"},{"issue":"1\u20132","key":"5579_CR58","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/21678421.2017.1406953","volume":"19","author":"DK Horton","year":"2018","unstructured":"Horton DK, Graham S, Punjani R et al (2018) A spatial analysis of amyotrophic lateral sclerosis (ALS) cases in the United States and their proximity to multidisciplinary ALS clinics. Amyotroph Lateral Scler Frontotemporal Degener 19(1\u20132):126\u2013133","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"5","key":"5579_CR59","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gutjnl-2020-322065","volume":"70","author":"JBY So","year":"2021","unstructured":"So JBY, Kapoor R, Zhu F et al (2021) Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population. Gut 70(5):829\u2013837","journal-title":"Gut"},{"key":"5579_CR60","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1007\/s12035-021-02323-y","volume":"58","author":"Z Dong","year":"2021","unstructured":"Dong Z, Gu H, Guo Q et al (2021) Profiling of serum exosome MiRNA reveals the potential of a MiRNA panel as diagnostic biomarker for Alzheimer\u2019s disease. Mol Neurobiol 58:3084\u20133094","journal-title":"Mol Neurobiol"},{"issue":"11","key":"5579_CR61","doi-asserted-by":"publisher","first-page":"e0240855","DOI":"10.1371\/journal.pone.0240855","volume":"15","author":"S Fazeli","year":"2020","unstructured":"Fazeli S, Motovali-Bashi M, Peymani M et al (2020) Correction: A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson\u2019s patients is associated with the early-stage onset of disease. PLoS ONE 15(11):e0240855","journal-title":"PLoS ONE"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05579-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05579-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05579-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T11:05:14Z","timestamp":1766055914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05579-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5579"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05579-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study. Since this study used only de-identified participant data, Advarra IRB (Pro00053269) determined that it \u201cdoes not meet the DHHS definition of human subjects research under 45 CFR 46 and, therefore, does not require IRB oversight.\u201d Sample collections were overseen by each respective institution (US National ALS Biorepository, CDC, Advarra Institutional Review Board, Pro00053269; Phase IIa clinical trial, NCT03580616, 2018-06-26, Dartmouth IRB D18095; Innovative Research Inc., Novi, MI, Food and Drug Administration (FDA) approval, #3003372368; Precision for Medicine, Norton, MA, CR00425931).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The not-for-profit research institute Brain Chemistry Labs has applied for a patent on the use of this biomarker.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"298"}}